U.S. health officials have endorsed the first blood test that can help diagnose Alzheimer’s. The test would help identify ...

The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the ...

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.

Lecanemab binds with high affinity to soluble amyloid-beta protofibrils. It won full FDA approval in July 2023 based on trial ...

The test can aid doctors in determining whether a patient’s memory problems are due to Alzheimer’s or a number of other ...

Alzheimer's disease prevalence is a primary driver of the Leqembi market. This degenerative brain disorder gradually impacts memory and cognition, influenced by genetic, lifestyle, and environmental ...

The findings show that memory clinics can have “the infrastructure and expertise to safely administer and care for patients ...

Lecanemab and donanemab (Kisunla), another anti-amyloid treatment, won approval based on evidence that they slowed cognitive ...

The company invented Leqembi® (lecanemab) – the world's first drug proven to slow the progression of the disease and reduce cognitive impairment in early Alzheimer's disease. Leqembi has been ...

Now, a simple blood test could finally offer families like hers the clarity they’ve long needed.The US Food and Drug ...